These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8878799

  • 1. Isocyanate-induced occupational asthma: challenge and immunologic studies.
    Park HS, Nahm DH.
    J Korean Med Sci; 1996 Aug; 11(4):314-8. PubMed ID: 8878799
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immunological evaluation of isocyanate-exposed workers.
    Park HS, Park JN, Kim JW, Kim SK.
    J Korean Med Sci; 1992 Jun; 7(2):122-7. PubMed ID: 1326284
    [Abstract] [Full Text] [Related]

  • 3. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
    Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, Ahn SW.
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):293-8. PubMed ID: 15478392
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS, Nahm DH.
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge.
    Karol MH, Tollerud DJ, Campbell TP, Fabbri L, Maestrelli P, Saetta M, Mapp CE.
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):611-5. PubMed ID: 8118626
    [Abstract] [Full Text] [Related]

  • 6. Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma.
    Park HS, Lee SK, Kim HY, Nahm DH, Kim SS.
    Clin Exp Allergy; 2002 Apr; 32(4):551-5. PubMed ID: 11972601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate.
    Kim H, Kim YD, Choi J.
    Environ Res; 1997 Oct; 75(1):1-6. PubMed ID: 9356188
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of IgE response to TDI-HSA conjugates by ELISA in toluene diisocyanate (TDI) -induced occupational asthma (OA) patients.
    Son M, Lee M, Kim YT, Youn JK, Park H.
    J Korean Med Sci; 1998 Apr; 13(2):147-52. PubMed ID: 9610614
    [Abstract] [Full Text] [Related]

  • 10. Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure.
    Pisati G, Baruffini A, Bernabeo F, Cerri S, Mangili A.
    Int Arch Occup Environ Health; 2007 Feb; 80(4):298-305. PubMed ID: 16957957
    [Abstract] [Full Text] [Related]

  • 11. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results.
    Park HS, Kim HY, Nahm DH, Son JW, Kim YY.
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):847-51. PubMed ID: 10518831
    [Abstract] [Full Text] [Related]

  • 12. [Occupational toluene diisocyanate (TDI) asthma--inhalation challenge test and TDI-HSA (human serum albumin) skin test and detection of specific IgE].
    Duan YY.
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):149-52, 191. PubMed ID: 2553281
    [Abstract] [Full Text] [Related]

  • 13. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.
    Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS.
    Int Arch Allergy Immunol; 2009 Jun; 150(2):156-63. PubMed ID: 19439981
    [Abstract] [Full Text] [Related]

  • 14. Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients.
    Park HS, Kim HY, Lee SK, Kim SS, Nahm DH.
    J Korean Med Sci; 2001 Feb; 16(1):57-61. PubMed ID: 11289402
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal study of specific antibodies to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate in patients with TDI-induced asthma.
    Park HS, Lee SK, Lee YM, Kim SS, Nahm DH.
    Korean J Intern Med; 2002 Dec; 17(4):249-51. PubMed ID: 12647640
    [Abstract] [Full Text] [Related]

  • 16. Role of tumor necrosis factor in toluene diisocyanate asthma.
    Matheson JM, Lemus R, Lange RW, Karol MH, Luster MI.
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):396-405. PubMed ID: 12356572
    [Abstract] [Full Text] [Related]

  • 17. Serum specific IgG response to toluene diisocyanate-tissue transglutaminase conjugate in toluene diisocyanate-induced occupational asthmatics.
    Pham le D, Kim MA, Yoon MG, Lee SI, Shin YS, Park HS.
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):48-54. PubMed ID: 24950844
    [Abstract] [Full Text] [Related]

  • 18. Toluene-diisocyanate induced asthma: evaluation of antibodies in the serum of affected workers against a tolyl mono-isocyanate protein conjugate.
    Danks JM, Cromwell O, Buckingham JA, Newman-Taylor AJ, Davies RJ.
    Clin Allergy; 1981 Mar; 11(2):161-8. PubMed ID: 6263516
    [Abstract] [Full Text] [Related]

  • 19. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study.
    Kopferschmitt-Kubler MC, Frossard N, Rohde G, Pauli G.
    Respir Med; 1998 Sep; 92(9):1093-8. PubMed ID: 9926161
    [Abstract] [Full Text] [Related]

  • 20. TDI-induced oculorhinitis and bronchial asthma.
    Paggiaro PL, Rossi O, Lastrucci L, Pardi F, Pezzini A, Baschieri L.
    J Occup Med; 1985 Jan; 27(1):51-2. PubMed ID: 2982003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.